GPD2 and cancer: Metformin is a Complex I inhibitor, providing cancer metabolism suppression through downregulation of mitochondrial glycerophosphate dehydrogenase (mGPDH) and OXPHOS inhibition, leading to decreased metastasis levels in a thyroid cancer mouse model (Thakur et al., 2018).